Global Antiviral Drugs Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2021 – Market Research Report 2017
OrbisResearch.com has published new research report on “Global Antiviral Drugs Market by Application, End Users, and Region-Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021” to its database.
Dallas, United States – July 10, 2017 /MarketersMedia/ —
The Global Antiviral Drugs Market is expected to reach USD 37.40 billion by 2021 from USD 29.16 billion in 2016, growing at a CAGR of 5.10% during the forecast period 2016-2021. Antiviral drugs are described as curative or disease controlling agents against viral infections. These drugs specifically attack viruses at different metabolic processes and alter the normal functioning of viral particles. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections.
The growth of Antiviral Drugs market is majorly driven by factors such as increase in public awareness, rise in healthcare expenditure, boost in Research and Development segment, emergence of life-threatening diseases, growing interest to support the development of novel antiviral drugs, existence of well-established supply chain. In addition, increasing incidence rates of viral infections is also fuelling the antiviral drugs market growth, such as according to World Health Organization, HIV/AIDS continues to be the major threat claiming more than 35 million lives so far. Globally, approximately 1.1 million lost their lives due to HIV in 2015. Approximately, 36.7 million people have been suffering from HIV in 2015. Furthermore, as late stage pipeline drugs are anticipated to hit the market, this further supports the antiviral drugs market growth. The key restraints of the market are high cost involved in drug development, increase in demand for alternative medicines (naturopathy, homeopathy, and oriental medicines), growing resistance among viruses against different antiviral drugs causing difficulty in developing broad-spectrum anti-viral drugs, restricted trade policies, lack of incentivization, and side-effects of products (nausea, diarrhea, and behavioral changes).
The global Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA Polymerase, NS3 Protease, Reverse Transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/345709
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 34.0% in the global antiviral drugs market. Whereas, Asia-Pacific is projected to grow at the highest CAGR of 6.12% during forecast period 2016-2021.
The major companies dominating the global Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
Buy the report@http://www.orbisresearch.com/contact/purchase/345709
Major Points From The Table Of Contents:
Introduction
Research Methodology
Overview
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Market Segmentation
Geographical Analysis
Strategic Analysis
Market Leaders’ Analysis
Competitive Landscape
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817
For more information, please visit http://www.orbisresearch.com/reports/index/global-antiviral-drugs-market-by-application-end-users-and-region-global-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021
Source: MarketersMedia
Release ID: 215808
Copyright © 1999-2013 SproutNews.com
